Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report | Zendy

Rama Chaudhry | Zendy; K. Sreenath | Zendy; E. V. Vinayaraj | Zendy; Biswajeet Sahoo | Zendy; M. R. Vishnu Narayanan | Zendy; K. V. P. Sai Kiran | Zendy; Priyam Batra | Zendy; Nisha Rathor | Zendy; Sheetal Singh | Zendy; Anant Mohan | Zendy; Sushma Bhatnagar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report

Author(s) -

Rama Chaudhry,

K. Sreenath,

E. V. Vinayaraj,

Biswajeet Sahoo,

M. R. Vishnu Narayanan,

K. V. P. Sai Kiran,

Priyam Batra,

Nisha Rathor,

Sheetal Singh,

Anant Mohan,

Sushma Bhatnagar

Publication year - 2021

Publication title -

access microbiology

Language(s) - English

Resource type - Journals

ISSN - 2516-8290

DOI - 10.1099/acmi.0.000212

Subject(s) - mycoplasma pneumoniae , pneumonia , medicine , pathogen , atypical pneumonia , outbreak , covid-19 , mycoplasmataceae , intensive care medicine , virology , mycoplasma , immunology , microbiology and biotechnology , biology , mollicutes , infectious disease (medical specialty) , disease

We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) andMycoplasma pneumoniaein a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 andM. pneumoniaeis infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research